Amarin Corp Plcuk (AMRN) EBT Growth (5y) (2015 - 2026)

Amarin Corp Plcuk (AMRN) EBT Growth (5y) (2015 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -54.16%
Dec 31, 2025 -15.11%
Sep 30, 2025 -5.00%
Jun 30, 2025 -38.23%
Mar 31, 2025 9.87%
Dec 31, 2024 -11.25%
Sep 30, 2024 -44.13%
Jun 30, 2024 29.12%
Mar 31, 2024 18.74%
Dec 31, 2023 -15.27%
Sep 30, 2023 5.13%
Jun 30, 2023 12.14%
Mar 31, 2023 9.66%
Dec 31, 2022 66.70%
Sep 30, 2022 18.54%
Jun 30, 2022 -36.58%
Mar 31, 2022 -6.25%
Dec 31, 2021 -20.95%
Sep 30, 2021 5.03%
Jun 30, 2021 21.21%